{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:09:50Z","timestamp":1778717390858,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National High-Level Hospital Clinical Research Funding","award":["2023HQ02"],"award-info":[{"award-number":["2023HQ02"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2703603"],"award-info":[{"award-number":["2022YFC2703603"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04934-w","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:25:30Z","timestamp":1775208330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SPARC upregulation mediates podocyte injury in Alport syndrome mice"],"prefix":"10.1186","volume":"27","author":[{"given":"Dongxuan","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"4934_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1681\/asn.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998;9:1736\u201350. https:\/\/doi.org\/10.1681\/asn.V991736.","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR2","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1113\/jphysiol.2014.274449","volume":"592","author":"J Savige","year":"2014","unstructured":"Savige J. Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol. 2014;592:4013\u201323. https:\/\/doi.org\/10.1113\/jphysiol.2014.274449.","journal-title":"J Physiol"},{"key":"4934_CR3","doi-asserted-by":"publisher","first-page":"846152","DOI":"10.3389\/fmed.2022.846152","volume":"9","author":"D Cosgrove","year":"2022","unstructured":"Cosgrove D, Madison J. Molecular and cellular mechanisms underlying the initiation and progression of alport glomerular pathology. Front Med. 2022;9:846152. https:\/\/doi.org\/10.3389\/fmed.2022.846152.","journal-title":"Front Med"},{"key":"4934_CR4","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","volume":"89","author":"M Nagata","year":"2016","unstructured":"Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89:1221\u201330. https:\/\/doi.org\/10.1016\/j.kint.2016.01.012.","journal-title":"Kidney Int"},{"key":"4934_CR5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.kint.2017.05.017","volume":"92","author":"F Ding","year":"2017","unstructured":"Ding F, Wickman L, Wang SQ, Zhang Y, Wang F, Afshinnia F, et al. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome. Kidney Int. 2017;92:1515\u201325. https:\/\/doi.org\/10.1016\/j.kint.2017.05.017.","journal-title":"Kidney Int"},{"key":"4934_CR6","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Pulleiro R, Garc\u00eda-Murias M, Fidalgo-D\u00edaz M, Garc\u00eda-Gonz\u00e1lez M. Molecular basis, diagnostic challenges and therapeutic approaches of Alport syndrome: a primer for clinicians. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222011063.","DOI":"10.3390\/ijms222011063"},{"key":"4934_CR7","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1177\/002215549904701201","volume":"47","author":"Q Yan","year":"1999","unstructured":"Yan Q, Sage EH. SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem. 1999;47:1495\u2013506. https:\/\/doi.org\/10.1177\/002215549904701201.","journal-title":"J Histochem Cytochem"},{"key":"4934_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s001250051493","volume":"43","author":"M Kanauchi","year":"2000","unstructured":"Kanauchi M, Nishioka M, Dohi K. Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury. Diabetologia. 2000;43:1076\u20137. https:\/\/doi.org\/10.1007\/s001250051493.","journal-title":"Diabetologia"},{"key":"4934_CR9","doi-asserted-by":"publisher","first-page":"F577","DOI":"10.1152\/ajprenal.00393.2004","volume":"289","author":"RV Durvasula","year":"2005","unstructured":"Durvasula RV, Shankland SJ. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis. Am J Physiol Ren Physiol. 2005;289:F577\u2013584. https:\/\/doi.org\/10.1152\/ajprenal.00393.2004.","journal-title":"Am J Physiol Ren Physiol"},{"key":"4934_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.critrevonc.2017.01.006","volume":"111L","author":"VB Mathema","year":"2017","unstructured":"Mathema VB, Na-Bangchang K. Regulatory roles of brain-specific angiogenesis inhibitor 1(BAI1) protein in inflammation, tumorigenesis and phagocytosis: A brief review. Crit Rev Oncol Hematol. 2017;111L:81\u20136. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.01.006.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4934_CR11","doi-asserted-by":"publisher","unstructured":"Niu YY, Yu Y, Zhou WQ, Zhang XQ, Zhu SY, Zhang YY, et al. Elevated serum and urinary secreted protein acidic and rich in cysteine levels are novel biomarkers of kidney fibrosis severity. Arch Med Res. 2024;56:103125. https:\/\/doi.org\/10.1016\/j.arcmed.2024.103125.","DOI":"10.1016\/j.arcmed.2024.103125"},{"key":"4934_CR12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s001250051493","volume":"43","author":"M Kanauchi","year":"2000","unstructured":"Kanauchi M, Nishioka M, Dohi K. Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury. Diabetologia. 2000;43:1076\u20137. https:\/\/doi.org\/10.1007\/s001250051493.","journal-title":"Diabetologia"},{"key":"4934_CR13","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2353\/ajpath.2009.080464","volume":"174","author":"AN Sussman","year":"2009","unstructured":"Sussman AN, Sun T, Krofft RM, Durvasula RV. SPARC accelerates disease progression in experimental crescentic glomerulonephritis. Am J Pathol. 2009;174:1827\u201336. https:\/\/doi.org\/10.2353\/ajpath.2009.080464.","journal-title":"Am J Pathol"},{"key":"4934_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/01.asn.0000054498.83125.90","volume":"14","author":"S Taneda","year":"2003","unstructured":"Taneda S, et al. Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol. 2003;14:968\u201380. https:\/\/doi.org\/10.1097\/01.asn.0000054498.83125.90. (2003).","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR15","doi-asserted-by":"publisher","first-page":"e70081","DOI":"10.1111\/apha.70081","volume":"241","author":"D Loreth","year":"2025","unstructured":"Loreth D, Sachs W, Meyer-Schwesinger C. The life of a kidney podocyte. Acta Physiol. 2025;241:e70081. https:\/\/doi.org\/10.1111\/apha.70081.","journal-title":"Acta Physiol"},{"key":"4934_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.ekir.2024.01.010","volume":"9","author":"A Niasse","year":"2024","unstructured":"Niasse A, Louis K, Lenoir O, Schwarz C, Xu X, Couturier A, et al. Protective role of the podocyte IL-15\/STAT5 pathway in focal Segmental Glomerulosclerosis. Kidney Int Rep. 2024;9:1093\u2013106. https:\/\/doi.org\/10.1016\/j.ekir.2024.01.010.","journal-title":"Kidney Int Rep"},{"key":"4934_CR17","doi-asserted-by":"publisher","unstructured":"Li L, Li J, Li R, Zhao X, Chen Y, Cai Y, et al. Podocyte RIPK3 deletion improves diabetic kidney disease by attenuating NF-\u03baB p65 driven inflammation. Adv Sci. 2025:e03325. https:\/\/doi.org\/10.1002\/advs.202503325.","DOI":"10.1002\/advs.202503325"},{"key":"4934_CR18","doi-asserted-by":"publisher","first-page":"1335936","DOI":"10.3389\/fimmu.2023.1335936","volume":"14","author":"H Jiang","year":"2023","unstructured":"Jiang H, Shen Z, Zhuang J, Lu Chen, Qu Y, Xu C, et al. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy. Front Immunol. 2023;14:1335936. https:\/\/doi.org\/10.3389\/fimmu.2023.1335936.","journal-title":"Front Immunol"},{"key":"4934_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11926-024-01175-4","volume":"27","author":"K Maeda","year":"2024","unstructured":"Maeda K, Abdi R, Tsokos GC. The role of podocytes in lupus pathology. Curr Rheumatol Rep. 2024;27:10. https:\/\/doi.org\/10.1007\/s11926-024-01175-4.","journal-title":"Curr Rheumatol Rep"},{"key":"4934_CR20","doi-asserted-by":"publisher","unstructured":"Altintas MM, Agarwal S, Sudhini Y, Zhu K, Wei C, Reiser J. Pathogenesis of focal segmental glomerulosclerosis and related disorders. Annu Rev Pathol. 20:329\u201353, https:\/\/doi.org\/10.1146\/annurev-pathol-051220-092001.","DOI":"10.1146\/annurev-pathol-051220-092001"},{"key":"4934_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto SKEGG. Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"key":"4934_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53:D672\u201377. https:\/\/doi.org\/10.1093\/nar\/gkae909.","journal-title":"Nucleic Acids Res"},{"key":"4934_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947\u201351. https:\/\/doi.org\/10.1002\/pro.3715.","journal-title":"Protein Sci"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04934-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04934-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04934-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:25:32Z","timestamp":1778714732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04934-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4934"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04934-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures were performed following the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and approved by the Laboratory Animal Ethics Committee of Peking University First Hospital (Animal Ethics Committee Approval Number: J2023102). Mice were anesthetized with 0.5% pentobarbital sodium (50\u201360\u00a0mg\/kg) by intraperitoneal injection, a whole blood sample was collected by cardiac puncture at the end of experiments. This study was approved by the Ethics Committee of Peking University First Hospital (Approval No.: (2020[72]), 1179) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants or their legal guardians before sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}